
View larger version (90K):
[in this window]
[in a new window]
|
Fig. 6. The effect of dominant-negative RhoA on ciliogenesis and ezrin localization. (A) Adenovirus-mediated overexpression of dominant-negative RhoA (AdRhoAN19) in cells co-expressing cilia marker Sp17 (arrows). At ALI day 0, mTEC cultures were infected with a tetracycline regulated (tet-off) adenovirus vector system (AdtTA) to control the expression of AdRhoAN19 by continuous incubation without or with doxycyline (Dox), then immunostained at ALI day 5. Bar, 10 µm. (B) -tubulin-IV, -tubulin, ezrin and Foxj1 in mTEC cultures infected with RhoAN19 and AdtTA as in A treated without or with doxycyline. (C) The percentage of cells transfected with RhoAN19 with apical localization of ciliated cell markers ( -tubulin, -tubulin, ezrin) and Foxj1 (nuclear) in the absence or presence of doxycyline. Data are the mean values ± s.d.; *P<0.05, significance in the absence of doxycyline. (D) Western blots showing expression of ezrin and moesin in mTEC cultured on plastic dishes treated with siRNA containing scrambled (Scr) or three pooled ezrin-specific (Ezr) sequences. (E) -tubulin-IV and ezrin in mTEC cultures treated with medium, Scr or pool ezrin siRNA sequences at ALI day 2 through ALI day 5, then immunostained for cilia ( -tubulin-IV, green) and ezrin (red) at ALI day 5. (F) The percentage of cells co-expressing -tubulin-IV and ezrin (mean ± s.d.) following treatment with media, scrambled sequence (scram) siRNA or ezrin-specific siRNA. Shown are the mean values ± s.d. (from three independent experiments); *P<0.05, significance compared with control conditions.
|